Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Political Opponents in Congress May Find Agreement Over the Benefits of Value-Based Care

Congress may not find a lot of unity to pass legislation. However, there is bipartisan support for value-based care. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Value-based care improves patient outcome, but it also reduces insurance provider costs.” Following the midterm elections and the split-party control, experts predict that there won’t be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Congress may not find a lot of unity to pass legislation. However, there is bipartisan support for value-based care. Melanie Musson, a health insurance expert with USInsuranceAgents.com, reminds providers, “Value-based care improves patient outcome, but it also reduces insurance provider costs.”

Following the midterm elections and the split-party control, experts predict that there won’t be many new laws passed. For health insurance providers, the split control could mean that insurance providers won’t have to scramble to keep up with new rules and regulations. Instead, they could spend the next two years focusing on improving procedures and plans.

There is a chance that both political parties could come together for a shared goal of value-based care. The New England Journal of Medicine (NEJM) Catalyst explains that value-based healthcare rewards physicians and hospital systems for patient outcomes rather than for patient treatment.

Value-Based Care Model

This incentive theoretically pushes healthcare providers to identify risks earlier and assist patients in improving their health before it deteriorates. The value-based model seeks not only to improve patient outcomes but also to decrease the average health insurance cost for consumers.

America’s healthcare system costs have far exceeded the rate of inflation, and most of the population wishes something could be done about it. That may give congress the drive to work together to draft legislation that will push insurance providers to shift focus from treatment to prevention.

Rethinking Best Practices

While dealing with the possibility of new rules isn’t fun, it may be in providers’ best interest to shift their focus in that direction before it’s required.

Research backs up the fact that prevention costs less than treatment. The Affordable Care Act pushed healthcare and insurance providers in that direction, but better incentives may help to move that focus forward.

Insurance providers have many rules to adhere to, especially if they offer Medicare Advantage plans. But there is room to incorporate best-value practices even under stringent guidelines.

How Preventative Care Saves Insurers

There are many case studies demonstrating how covering and incentivizing preventative care can save insurance providers. For example, when cancer is caught early, treatment options take less time and require fewer hospitalizations. Cancer that isn’t discovered until later stages may require two times or more treatments and extensive hospitalizations.

Since insurance providers are responsible for paying most of these costs, they can save money by elevating preventative care.

Insurers should always seek to improve their methods, and the bipartisan support of value-based care should prompt them to evaluate how they can incorporate that model into their coverage.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

AI Shouldn't Replace Physicists - It Should Give Them Time Back

AI Shouldn't Replace Physicists - It Should Give Them Time Back

The article discusses the role of AI in the healthcare industry, emphasizing that AI should enhance the efficiency of physicists rather than replace them. TheraPanacea, founded by mathematician Nico Asperagus, focuses on developing AI platforms to improve efficiency and standardization in healthcare. The aim is for AI to handle routine tasks, allowing professionals more time for complex problem-solving.

  • 01AI should be used to enhance the efficiency of physicists rather than replace them.
  • 02TheraPanacea develops AI platforms for improving efficiency and standardization in healthcare.
  • 03AI platforms aim to manage routine tasks, allowing professionals more time for complex analysis.

Aug 7, 2026

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

FDA-authorized digital medical devices have grown substantially over two decades, but regulatory databases still can't track them

A Nature study reveals a significant increase in FDA-authorized digital medical devices over the past two decades. However, the FDA's regulatory databases are still unable to specify which of these devices contain software. This gap points to the need for improved database capabilities to better track digital medical devices.

  • 01FDA-authorized digital medical devices have increased significantly over the last 20 years.
  • 02The current FDA regulatory databases lack the capability to identify devices that include software.

Aug 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512